Polyrizon Ltd.
PLRZ | NASDAQ
$10.90
-$0.09 (-0.82%)
At close: Sep 21, 2026, 4:00 PM ET
$10.89
-$0.01 (-0.08%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Company Profile
Polyrizon Ltd. is an Israeli biotechnology firm specializing in the creation of medical device hydrogels, delivered as nasal sprays. These innovative sprays are designed to form a protective barrier within the nasal cavity, preventing viruses and allergens from attaching to the nasal epithelial tissue. Its current development pipeline features several targeted solutions, including PL-14, formulated to block nasal allergies; PL-15, aimed at combating COVID-19; and PL-16, for influenza prevention. Established in 2005, the company operates from its headquarters in Ra'anana, Israel.
Key Executives
| Name | Position |
|---|---|
| Tomer Izraeli | Founder, Chief Executive Officer & Director |
| Nir Ben Yosef | Chief Financial Officer & Compliance Officer |
| Tidhar Turgeman | Chief Technology Officer |
| Eyal S. Ron | Chief Scientific Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 04, 2026 | 6-K | Filing |
| Sep 04, 2026 | 6-K | Filing |
| Sep 04, 2026 | 424B5 | Filing |
| Aug 20, 2026 | 6-K | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jul 13, 2026 | 6-K | Filing |
| Jul 02, 2026 | 6-K | Filing |
| Jun 29, 2026 | 6-K | Filing |
| Jun 17, 2026 | 6-K | Filing |
| Jun 15, 2026 | 6-K | Filing |
Polyrizon Ltd.
| Country | Israel |
| IPO Date | Oct 28, 2024 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Tomer Izraeli |
Contact Details
5 Ha-Tidhar Street Ra'anana,
TA 4321545 Israel
Stock Details
| Ticker Symbol | PLRZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001893645 |
| CUSIP Number | M79549123 |
| ISIN Number | IL0011814113 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove PLRZ